Our clinic is located in a discreet office building in the heart of D.C. Your privacy is important to us, and each patient has their own private room. There are no waiting rooms and no lines, so you will likely never see another patient. We firmly believe that access to abortion is a right for all people regardless of the reason behind their decision. We offer a non-judgmental, compassionate, and supportive space for people to receive high quality care.

Our Services

Placement of Intrauterine Contraceptive Device with Sedation

We offer placement of Liletta intrauterine contraceptive device (IUD) under sedation. We combine multiple pain-reducing techniques with light oral or i.v. sedation for people who want an IUD placed with better pain control. Liletta is just like Mirena – same size and same low-dose of hormone – and both are approved for 6 years of use. Most people will experience a decrease of more than 80% in menstrual bleeding and a similar decrease in menstrual cramping. Many people will not menstruate due to the continuous release of a small dose of levonorgestrel (a hormone that prevents pregnancy) within the uterus – this is both a safe and common side effect.

Diagnosis and Management of Ectopic Pregnancy

We specialize in diagnosis and management of ectopic pregnancy of all types. Whether the pregnancy is located in the Fallopian tube, cervix, uterine cornua, cesarean scar, or elsewhere in the pelvis, we can accurately diagnose the ectopic pregnancy and develop a minimally invasive management plan. We have successfully treated cesarean scar implantations without surgery. Similarly, we have treated tubal ectopics, cornual ectopics and cervical ectopic pregnancies with ultrasound-guided therapies. We tailor the management plan to the specifics of each patient’s case.

The Abortion Pill

We offer the abortion pill, also commonly known as medication abortion 10 weeks into pregnancy. If you have missed one or two periods, you can end your pregnancy with a medication abortion. This is a safe and effective way to end your pregnancy using a combination of misoprostol and mifepristone to induce a miscarriage in the comfort and privacy of your own home.

First-Trimester Abortion

Many patients choose to end their pregnancy with a short, simple in-clinic procedure, known as a uterine aspiration. This abortion option removes the pregnancy with light suction from a handheld device. The entire appointment typically lasts less than two hours, and the vast majority is spent in the privacy of your own patient room where your partner, family members, or friends may be with you. We use multiple methods to reduce pain, including i.v. sedation at no additional fee.

Abortion from 16-26 weeks

If you are between 16 and 26 weeks along in your pregnancy, we can provide you with abortion care.

Abortion after 26 weeks

If you are farther than 26 weeks into your pregnancy, we can still see you.

Our Providers

Matthew Reeves, MD MPH FACOG

Dr. Matthew Reeves is a board-certified obstetrician-gynecologist. Dr. Reeves attended Harvard Medical School and completed a residency in obstetrics and gynecology at the University of California, San Francisco (UCSF). Following his residency, Dr. Reeves completed a Fellowship in Clinical Ultrasound at the UCSF Department of Radiology followed by the Fellowship in Family Planning and Contraceptive Research at the University of Pittsburgh.

Jennefer Russo, MD, MPH, FACOG

 

Dr. Jennefer Russo is a graduate of Cornell University with a Bachelor of Science with Honors, George Washington University School of Medicine, and the University of Pittsburgh Master of Public Health program. She completed her residency in Obstetrics and Gynecology at Harbor-UCLA Medical Center. She was a National Health Service Scholar. After residency, she served in a federally qualified health center in San Diego and then returned to training as a complex family planning specialist at the University of Pittsburgh.

Jessica Kuperstock, MD MPH FACOG, Medical Director

 

Dr. Kuperstock is a board-certified obstetrician-gynecologist. Dr. Kuperstock attended Stanford University School of Medicine and completed a residency in obstetrics and gynecology at Beth-Israel Deaconess Hospital at Harvard Medical School. She then completed a Fellowship in Family Planning at Brigham and Womens Hospital at Harvard Medical School.

Request Appointment

If you would like to request an

appointment at our clinic

Refer a Patient

If you would like to refer a patient or

discuss a potential referral

Dr. Matthew Reeves
Matthew Reeves, MD, MPH, FACOG, is the Executive Director and founder of the DuPont Clinic.  With the team at the DuPont Clinic, Dr. Reeves has worked to re-envision the patient experience, create a new patient flow without a waiting room, develop new shortened protocols for later abortion, improve pain control techniques, and develop improved gynecologic instruments.

Dr. Reeves maintains hospital privileges at Sibley Memorial Hospital, George Washington University Hospital, and Medstar Washington Hospital Center. In addition to his role at DuPont Clinic, Dr. Reeves holds appointments as an Adjunct Clinical Associate Professor of Obstetrics and Gynecology at Stanford University School of Medicine and as an Adjunct Associate Professor at the Johns Hopkins Bloomberg School of Public Health.

Dr. Reeves also serves on the board of directors of DKT International, a social marketing organization that provided over 44 million couple-years of contraception in over 25 countries and is now the sole distributor for Ipas aspirators and Sino-Implant II. Dr. Reeves also is a member of the Editorial Board of BMJ Sexual & Reproductive Health. Previously, Dr. Reeves served as the first Medical Director of the National Abortion Federation. In that role, he was responsible for the NAF Clinical Policy Guidelines and worked to improve the quality of abortion care across North and South America. From 2010 to 2014, Dr. Reeves was the Chief Medical Officer of WomenCare Global, where his work focused on expanding use of manual uterine aspiration and introducing mifepristone and levonorgestrel implants to new markets globally. He also served as a Medical Officer at CONRAD at Eastern Virginia Medical School, focusing on early stage development of new contraceptive and HIV-prevention products. Prior to moving to Washington, DC, in 2009, he was on faculty at the University of Pittsburgh School of Medicine and an attending physician at Magee-Womens Hospital working in both the Ultrasound and Gynecologic Specialties divisions. Dr. Reeves has conducted research on gynecologic  ultrasound, contraceptive development, early phase clinical trials of HIV-prevention products, cost-effectiveness, and provision of reproductive health services globally. Dr. Reeves has conducted trainings on clinical ultrasound, intrauterine and subdermal contraception, uterine aspiration, and mifepristone in English and in Spanish in North and South America, Africa, Europe, and Asia.

Dr. Reeves attended Harvard Medical School and completed a residency in obstetrics and gynecology at the University of California, San Francisco (UCSF). Following his residency, Dr. Reeves completed a Fellowship in Clinical Ultrasound at the UCSF Department of Radiology followed by the Fellowship in Family Planning and Contraceptive Research at the University of Pittsburgh. Dr. Reeves has been a Fellow in the American College of Obstetricians & Gynecologists since 2008 and a Fellow in the Society of Family Planning, also since 2008. He is also an active member of the American Institute of Ultrasound in Medicine and the International Society of Ultrasound in Obstetrics and Gynecology.

When not working, Dr. Reeves enjoys swimming, running, biking, and trying to grow orchids. He loves to travel with his family.

Skip to content